Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17-hydroxyprogesterone caproate in PPROM
NCT04807543Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyprogesterone caproate in preterm premature rupture of membranes (pPROM), sponsored by Ain Shams University. Started Jan 2018; status: completed.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT04807543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04807543.